Abstract

BackgroundThe limited cell dose in umbilical cord blood (UCB) necessitates ex vivo expansion of UCB. Further, the effective cryopreservation of these expanded cells is important in widening their use in the clinics. During cryopreservation, cells experience oxidative stress due to the generation of reactive oxygen species (ROS). Conditioned medium from mesenchymal stem cells (MSCs-CM) has been shown to alleviate the oxidative stress during wound healing, Alzheimer’s disease and ischemic disease. This premise prompted us to investigate the influence of MSCs-CM during cryopreservation of expanded UCB cells.Methodology/Principle findingsCM-was collected from cord/placental MSCs(C-MSCs-CM, P-MSC-CM). UCB CD34+cells were expanded as suspension cultures in serum free medium containing cytokines for 10 days. Cells were frozen with/without C-MSCs-CM and or P-MSCs-CM in the conventional freezing medium containing 20%FCS +10%DMSO using a programmable freezer and stored in liquid nitrogen. Upon revival, cells frozen with MSCs-CM were found to be superior to cells frozen in conventional medium in terms of viability, CD34+content and clonogenecity. Priming of revived cells for 48 hrs with MSCs-CM further improved their transplantation ability, as compared to those cultured without MSCs-CM. P-MSCs-CM radically reduced the oxidative stress in cryopreserved cells, resulting in better post thaw functionality of CD34+ cells than with C-MSCs-CM. The observed cryoprotective effect of MSCs-CM was primarily due to anti-oxidative and anti-apoptotic properties of the MSCs-CM and not because of the exosomes secreted by them.Conclusions/SignificanceOur data suggest that MSCs-CM can serve as a valuable additive to the freezing or the priming medium for expanded UCB cells, which would increase their clinical applicability.

Highlights

  • Umbilical cord blood (UCB) has been widely used as a source of hematopoietic stem cells (HSCs) for the treatment of acquired and hereditary diseases of the hematopoietic system [1,2,3]

  • Isolated UCB CD34+ cells were expanded in standard expansion medium (ExpMedium) for 10 days and were subjected to rate controlled freezing without or with conditioned medium of C-MSCs (C-MSCs CM set) or P-MSCs (P-MSCs CM set).The frozen cells were revived after 6–8 weeks, the viable cells were counted by trypan blue dye exclusion method and revival efficiency was estimated

  • Cells frozen with C-MSCs-CM (65.2±3.43%) and P-MSCs CM (82.54±1.5%) displayed a higher revival efficiency as compared to those in the control set (59.7±1.42%) (Fig 1A).This difference was significant in the P-MSCs-CM set

Read more

Summary

Introduction

Umbilical cord blood (UCB) has been widely used as a source of hematopoietic stem cells (HSCs) for the treatment of acquired and hereditary diseases of the hematopoietic system [1,2,3]. Due to the intricacies associated with transplantation procedures, expanded cells cannot be used directly for therapy. Both short-term and long-term storage of expanded grafts is warranted for their convenient transportation and for their use in the future. The limited cell dose in umbilical cord blood (UCB) necessitates ex vivo expansion of UCB. Conditioned medium from mesenchymal stem cells (MSCs-CM) has been shown to alleviate the oxidative stress during wound healing, Alzheimer’s disease and ischemic disease. This premise prompted us to investigate the influence of MSCs-CM during cryopreservation of expanded UCB cells

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call